New study tracks immunotherapy side effects to improve patient care
NCT ID NCT03447483
First seen Apr 23, 2026 · Last updated Apr 29, 2026 · Updated 1 time
Summary
This study followed 150 adults with solid tumors who were starting immunotherapy. Researchers collected data on side effects and quality of life during routine treatment. The goal was to better understand how and when side effects occur, helping doctors manage them more effectively in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH ALBI
Albi, France
-
Ch Castres
Castres, France
-
Hopital Larrey
Toulouse, 31059, France
-
Institut Curie
Paris, 75005, France
-
Institut Regional Du Cancer de Montpellier (Icm)
Montpellier, 34298, France
-
Institut Universitaire Du Cancer de Toulouse - Oncopole
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.